Diabetes and Pancreatic Cancer: Chicken or Egg?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pancreas

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPA.0b013e318209e05dPMID 21412116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Past medical history and pancreatic cancer risk: Results from a multicenter case-control study.

  2010cited by this paper
• Diabetes mellitus type 2 - an independent risk factor for cancer?

  2010cited by this paper
• Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer

  2010cited by this paper
• Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease

  2010cited by this paper
• but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.

  2009cited by this paper
• Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

  2009cited by this paper
• Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes

  2009cited by this paper
• Beneficial Endocrine but adverse Exocrine effects of Sitagliptin in the HIP rat model of Type 2 Diabetes, interactions with Metformin.

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

  2009cited by this paper
• Cancer Incidence and Mortality After Gastric Bypass Surgery

  2009cited by this paper
• Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.

  2009cited by this paper
• Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

  2009cited by this paper
• Diabetes prevalence and diagnosis in US states: analysis of health surveys

  2009cited by this paper
• Pancreatic duct replication is increased with obesity and type 2 diabetes in humans

  2009cited by this paper
• Antidiabetic therapies affect risk of pancreatic cancer.

  2009cited by this paper
• Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

  2008cited by this paper
• Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.

  2008cited by this paper
• In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

  2008cited by this paper
• Insulin and insulin-like growth factor signalling in neoplasia

  2008cited by this paper
• Bariatric surgery reduces cancer risk in morbidly obese patients.

  2008cited by this paper
• The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer.

  2007cited by this paper
• Mitogenic signaling pathways induced by G protein‐coupled receptors

  2007cited by this paper
• Resectability of Presymptomatic Pancreatic Cancer and Its Relationship to Onset of Diabetes: A Retrospective Review of CT Scans and Fasting Glucose Values Prior to Diagnosis

  2007cited by this paper
• Perioperative Mortality for Pancreatectomy: A National Perspective

  2007cited by this paper
• Mechanisms and Emerging Treatments of the Metabolic Complications of Chronic Pancreatitis

  2007cited by this paper
• Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

  2007cited by this paper
• Effects of bariatric surgery on mortality in Swedish obese subjects.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Diabetes mellitus in pancreatic cancer: is it a causal relationship?

  2007cited by this paper
• A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year

  2007cited by this paper
• Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

  2006cited by this paper
• Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.

  2006cited by this paper
• Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin

  2006cited by this paper
• Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?

  2006cited by this paper
• LKB1-dependent signaling pathways.

  2006cited by this paper
• The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

  2005cited by this paper
• Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer.

  2005cited by this paper
• Diabetes mellitus: a risk factor for pancreatic cancer?

  2005influential reference
• Probability of pancreatic cancer following diabetes: a population-based study.

  2005cited by this paper
• Fasting serum glucose level and cancer risk in Korean men and women.

  2005cited by this paper
• Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

  2005cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Population estimates.

  2004cited by this paper
• Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis.

  2004cited by this paper
• Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.

  2004cited by this paper
• The LKB1 tumor suppressor negatively regulates mTOR signaling.

  2004cited by this paper
• Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study

  2004cited by this paper
• Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?

  2004cited by this paper
• Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes

  2004cited by this paper
• Association of markers of insulin and glucose control with subsequent colorectal cancer risk.

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Exocrine Pancreatic Cancer, Cigarette Smoking, and Diabetes Mellitus: A Case-Control Study in Northern Italy

  2003cited by this paper
• Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC).

  2003cited by this paper
• Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds.

  2003cited by this paper
• Prospective study of diet and pancreatic cancer in male smokers.

  2002cited by this paper
• A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus

  2002cited by this paper
• Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: Findings from the Japan collaborative cohort study for evaluation of cancer risk

  2002cited by this paper
• Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.

  2001cited by this paper
• Risk factors for pancreatic cancer: a case-control study based on direct interviews.

  2001cited by this paper
• Early changes in islet hormone secretion in the hamster pancreatic cancer model.

  2001cited by this paper
• Prevention of pancreatic cancer induction in hamsters by metformin.

  2001cited by this paper
• Physical activity, obesity, height, and the risk of pancreatic cancer.

  2001cited by this paper
• Pancreatic Resection: Effects on Glucose Metabolism

  2001cited by this paper
• Physiological Concentrations of Insulin Augment Pancreatic Cancer Cell Proliferation and Glucose Utilization By Activating MAP Kinase, PI3 Kinase and Enhancing GLUT-1 Expression

  2000cited by this paper
• The intracellular mechanism of insulin resistance in pancreatic cancer patients.

  2000cited by this paper
• Socio-economic and lifestyle factors associated with the risk of prostate cancer

  2000cited by this paper
• Abnormal glucose metabolism and pancreatic cancer mortality.

  2000cited by this paper
• Pancreatic cancer and diabetes: is there a relationship? A case-controlled study.

  2000cited by this paper
• Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer

  1999cited by this paper
• Pancreatic Polypeptide and Glucose Metabolism

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Pancreatic cancer cells selectively stimulate islet cells to secrete amylin

  1998cited by this paper
• Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin.

  1998cited by this paper
• Diabetes mellitus and pancreaticcancer mortality in a prospectivecohort of United States adults

  1998cited by this paper
• Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

  1997cited by this paper
• Islet Hormone Secretion in Pancreatic Cancer Patients with Diabetes

  1997cited by this paper
• Risk factors for pancreatic cancer in Orientals

  1996cited by this paper
• Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.

  1996cited by this paper
• Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide.

  1995cited by this paper
• Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

  1995cited by this paper
• Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden.

  1995influential reference
• Diabetes and the risk of pancreatic cancer.

  1994cited by this paper
• A prospective study of pancreatic cancer in the elderly

  1994cited by this paper
• Diabetes mellitus in pancreatic cancer follow-up.

  1994cited by this paper
• Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.

  1994cited by this paper
• Diabetes and the risk of pancreatic cancer.

  1994cited by this paper
• Risk factors for pancreatic cancer: an exploratory study.

  1993cited by this paper
• Diabetes and pancreatic carcinoma.

  1993cited by this paper
• Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer

  1993cited by this paper
• Pancreatic cancer is associated with impaired glucose metabolism.

  1993cited by this paper
• Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster

  1993cited by this paper
• Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma

  1993cited by this paper
• [Diabetes mellitus and pancreatic cancer: a case-control study in greater Montreal, Quebec, Canada].

  1992cited by this paper
• Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men.

  1992cited by this paper
• Aspects of medical history and exocrine carcinoma of the pancreas: A population‐based case‐control study in The Netherlands

  1992cited by this paper
• The effect of pancreatic polypeptide on glucose disposal after surgical alterations of the pancreas.

  1992cited by this paper

• Unraveling the sweet connection between pancreatic cancer and hyperglycemia.

  2025cites this paper
• Correlation of cumulative fasting blood glucose exposure with gastrointestinal cancers: A prospective cohort study

  2025cites this paper
• Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case–Control Study

  2024cites this paper
• Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal–external validation of a clinical risk prediction model

  2024cites this paper
• Associations between Diabetes Mellitus and Selected Cancers

  2024cites this paper
• Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families

  2023cites this paper
• Pre-existing psychological disorders, diabetes, and pancreatic cancer: A population-based study of 38,952 Finns.

  2022cites this paper
• Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior

  2022cites this paper
• Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges

  2022cites this paper
• Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1

  2021cites this paper
• Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress

  2021cites this paper
• Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer

  2021cites this paper
• A review of lifestyle and environment risk factors for pancreatic cancer.

  2021cites this paper
• Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical prediction model (QPancreasD)

  2021cites this paper
• The biological and pharmacological connections between diabetes and various types of cancer.

  2021cites this paper
• Clinical Presentation and Symptoms in Pancreatic Cancer

  2021cites this paper
• Exploring prior diseases associated with pancreatic cancer.

  2021cites this paper
• Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments

  2020cites this paper
• Diabetes and cancer: Epidemiological and biological links

  2020cites this paper
• Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.

  2020cites this paper
• Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus

  2020cites this paper
• Risk factors for new-onset diabetes mellitus after distal pancreatectomy

  2020cites this paper
• Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704.

  2020cites this paper
• Defining Parallels between the Salivary Glands and Pancreas to Better Understand Pancreatic Carcinogenesis

  2020cites this paper
• Role of Fibre in Nutritional Management of Pancreatic Diseases

  2019cites this paper
• Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells

  2019cites this paper
• Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

  2019cites this paper
• Pancreatic Cancer: A Rare Cause of Abdominal Pain in Severe Cystic Fibrosis.

  2019cites this paper
• Insulin Resistance Is a Common Core Tethered to Diabetes and Pancreatic Cancer Risk

  2019cites this paper
• Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits

  2019cites this paper
• Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma

  2019cites this paper
• The relationship between pancreatic cancer and type 2 diabetes: cause and consequence

  2019cites this paper
• ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer.

  2019cites this paper
• Панкреатогенный сахарный диабет

  2019cites this paper
• The relationship between pancreatic cancer and type 2 diabetes: cause and consequence

  2019cites this paper
• From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research

  2019cites this paper
• Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes

  2018cites this paper
• Diabetes mellitus secondary to pancreatic diseases (type 3c): The effect of smoking on the exocrine–endocrine interactions of the pancreas

  2018cites this paper
• GxGrare: gene-gene interaction analysis method for rare variants from high-throughput sequencing data

  2018cites this paper
• LKB1 obliterates Snail stability and inhibits pancreatic cancer metastasis in response to metformin treatment

  2018cites this paper
• The dual role of HMGB1 in pancreatic cancer

  2018cites this paper
• Analysis of postoperative course after pancreatic resections – experience of one centre

  2018cites this paper
• ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China

  2018cites this paper
• Strengthening the research of pancreatogenic diabetes

  2018cites this paper
• Epidemiology and risk factors of pancreatic cancer

  2018cites this paper
• Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non–Diabetes Mellitus Patients

  2018cites this paper
• 11 Multi-Disciplinary Management of Metastatic Pancreatic Cancer

  2017cites this paper
• Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer

  2017cites this paper
• Early detection of sporadic pancreatic cancer: time for change.

  2017cites this paper
• High Glucose Accelerates Cell Proliferation and Increases the Secretion and mRNA Expression of Osteopontin in Human Pancreatic Duct Epithelial Cells

  2017cites this paper
• Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics

  2017cites this paper
• Cancer and Chemoprevention: An Overview

  2017cites this paper
• Pancreatogenic diabetes: etiology, implications, and management

  2017cites this paper
• Chemoprevention by Graviola

  2017cites this paper
• Altered profile of serum microRNAs in pancreatic cancer‐associated new‐onset diabetes mellitus

  2016cites this paper
• Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification

  2016cites this paper
• SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells

  2016cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2016cites this paper
• Diabetes Mellitus and Reprogrammed Glucose Metabolism in Pancreatic Cancer : Features for Clinical Translation

  2016cites this paper
• Intelligent system for diabetes prediction in patients with chronic pancreatitis

  2016cites this paper
• Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.

  2016cites this paper
• Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus.

  2016cites this paper
• Management of pancreatogenic diabetes: challenges and solutions

  2016cites this paper
• How Grim is Pancreatic Cancer?

  2016cites this paper
• Exocrine Pancreatic Insufficiency and Diabetes Mellitus

  2016cites this paper
• Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study

  2016cites this paper
• Statins and the risk of pancreatic cancer in Type 2 diabetic patients—A population‐based cohort study

  2016cites this paper
• Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs

  2016cites this paper
• Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis

  2015cites this paper
• Spatial modelling of type II diabetes outcomes: a systematic review of approaches used

  2015cites this paper
• Diatom-inspired skeletonisation of insulin - Mechanistic insights into crystallisation and extracellular bioactivity.

  2015cites this paper
• Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.

  2015cites this paper
• Diet and Pancreatic Cancer Prevention

  2015cites this paper
• Molecular targets for novel drug development in pancreatic cancer

  2015cites this paper
• Canonical Wnt signaling pathway contributes to the proliferation and survival in porcine pancreatic stem cells (PSCs)

  2015cites this paper
• Diabetes Mellittus and the Risk of Cancer Formation – Possible Link and Review of Literature

  2015cites this paper
• Glycemic Change After Pancreaticoduodenectomy

  2015cites this paper
• Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies

  2014cites this paper
• The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

  2014cites this paper
• Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell

  2014cites this paper
• Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies

  2014cites this paper
• Obesity and pancreatic cancer.

  2014cites this paper
• Immunological and Diabetological Features of Chronic Pancreatitis

  2014cites this paper
• Association between Allergies and Risk of Pancreatic Cancer

  2014cites this paper
• Metabolic Syndrome and Obesity : Targets and Therapy Dovepress

  2014cites this paper
• Strategies for early detection of resectable pancreatic cancer.

  2014cites this paper
• Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

  2014cites this paper
• Helicobacter pylori and pancreatic cancer risk: a meta- analysis based on 2,049 cases and 2,861 controls.

  2014cites this paper
• Tea drinking and risk of pancreatic cancer

  2014cites this paper
• Pancreatic exocrine insufficiency, diabetes mellitus and serum nutritional markers after acute pancreatitis.

  2014cites this paper
• The Role of Hyperinsulenemia as a Risk Factor for Pancreatic Cancer

  2013cites this paper
• [New-onset diabetes as an early sign of pancreatic cancer].

  2013cites this paper
• Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?

  2013cites this paper
• Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapy.

  2013cites this paper
• Diagnosis and treatment of diabetes mellitus in chronic pancreatitis.

  2013cites this paper
• Is diabetes mellitus a risk factor for pancreatic cancer?

  2013cites this paper
• Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells

  2013cites this paper
• [The importance of glycemic load of the diet in the development of cancer].

  2013cites this paper
• Maladies du pancréas exocrine et diabète

  2013cites this paper
• Cancer risk in immune-mediated inflammatory diseases (IMID)

  2013cites this paper